Published online July 1, 2005
PEDIATRICS Vol. 116 No. 1 July 2005, pp. 68-72 (doi:10.1542/10.1542/peds.2004-1129)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zadik, Z.
Right arrow Articles by Reifen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zadik, Z.
Right arrow Articles by Reifen, R.
Related Collections
Right arrow Nutrition & Metabolism
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effect of Nutrition on Growth in Short Stature Before and During Growth-Hormone Therapy

Zvi Zadik, MD*,{ddagger}, Tali Sinai, MSc{ddagger}, Amnon Zung, MD* and Ram Reifen, MD, MSc{ddagger}

* Pediatric Endocrine Unit, Kaplan Medical Center, Rehovot, Israel
{ddagger} School of Nutritional Sciences, Hebrew University of Jerusalem, Jerusalem, Israel

Objective. Although nutritional counseling is an integral part of the management of rapidly growing children, few studies have focused on the importance of nutritional supervision during growth-hormone (GH) therapy. The objective of this study was to study the effect of caloric intake on growth before and during GH therapy.

Methods. A total of 115 short normal prepubertal children who were 7.4 ± 1.2 years of age (mean ± SD) and had height SD score (SDS) of –2.5 ± 0.6 were treated with a GH dose range of 0.13 to 0.52 mg/kg per week for 1 year. A 3-day nutritional recall and blood chemistry analysis were repeated every 3 months.

Results. Caloric intake (expressed as % recommended dietary allowance) was positively correlated with the pretreatment growth velocity (SDS) and the increment in growth velocity SDS during the first year of GH therapy (r = 0.363 and 0.493). By stepwise regression analysis, we identified 4 parameters that could predict the 1-year increment in growth velocity SDS: the contribution of each factor (% variability) was pretreatment growth velocity SDS 36%, GH dose (27%), caloric intake 4%, and the integrated concentration of GH 2% (r2 = 0.689). GH therapy induced an alkaline phosphatase increment of 59 ± 49 IU/mL, an insulin-like growth factor-I increment of 32.6 ± 11.9 nmol/L, and a GH binding protein increment of 10.2 ± 2.7%. During GH therapy, an increase in serum transferrin (56.5 ± 35.2 mg/dL) and a decrease in serum iron (20.5.5 ± 20.2 µg/dL) were noted. These changes could not be detected through hemoglobin levels or hematopoietic indexes. Dietary iron supplementation reversed this phenomenon.

Conclusions. The nutritional status of GH-treated patients before and throughout the course of GH treatment should be monitored closely to improve the growth response and prevent nutritional deficiencies. Special emphasis should be placed on iron nurture.

Key Words: growth-hormone therapy • growth-hormone–binding protein • nutrition • iron

Abbreviations: GH, growth hormone • SDS, SD score • RDA, recommended dietary allowance • IGF-I, insulin-like growth factor-I • GHBP, growth-hormone–binding protein

Accepted Oct 21, 2004.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?